Skip to main content
    M

    Mustang Bio Inc (MBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.39
    +0.02 (+4.05%)

    Market Cap: $3.08M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(14/29)
    Avg Surprise
    -8.36%
    Streak
    2 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 5
    		$-0.16N/AN/ABeat+15.8%
    Mar 26
    Reported May 5
    		$-0.14N/AN/ABeat+85.1%
    Dec 25
    Reported Mar 19
    		$-0.07N/AN/ABeat-102.0%
    Sep 25
    Reported Nov 7
    		$-0.07N/AN/ABeat+96.5%
    Jun 25
    Reported Aug 8
    		$-0.19$0.00N/ABeat+98.4%
    Mar 25
    Reported May 14
    		$-0.95$0.00N/ABeat+95.9%
    Dec 24
    Reported Mar 24
    		$3.63N/A+145.38%Beat+522.1%
    Sep 24
    Reported Nov 8
    		$-2.00N/A+69.23%Beat+97.1%
    Jun 24
    Reported Aug 13
    		$-12.00$-7.00-71.43%Miss+88.0%
    Mar 24
    Reported May 15
    		$-23.00$-11.00-109.09%Miss+77.7%
    Dec 23
    Reported Mar 11
    		$-0.86$-1.33+35.34%Beat+68.1%
    Sep 23
    Reported Nov 14
    		$-69.81$-77.50+9.92%Beat+48.3%
    Jun 23
    Reported Aug 14
    		$-100.00$-85.75-16.62%Miss+29.8%
    Mar 23
    Reported May 12
    		$-103.00$-150.50+31.56%Beat+31.3%
    Dec 22
    Reported Mar 29
    		$-2.70$-2.89+6.57%Beat-1127.3%
    Sep 22
    Reported Nov 14
    		$-135.00$-147.50+8.47%Beat+5.3%
    Jun 22
    Reported Aug 11
    		$-142.50$-155.00+8.06%Beat-18.8%
    Mar 22
    Reported May 12
    		$-150.00$-140.00-7.14%Miss-5.3%
    Dec 21
    Reported Mar 23
    		$-0.22$-0.19-15.79%Miss+31.3%
    Sep 21
    Reported Nov 12
    		$-142.50$-127.50-11.76%Miss+17.4%
    Jun 21
    Reported Aug 16
    		$-120.00$-142.50+15.79%Beat+50.0%
    Mar 21
    Reported May 14
    		$-142.50$-127.50-11.76%Miss-50792.9%
    Dec 20
    Reported Mar 24
    		$-0.32$-0.21-52.38%Miss+99.9%
    Sep 20
    Reported Nov 6
    		$-172.50$-180.00+4.17%Beat+8.0%
    Jun 20
    Reported Aug 10
    		$-240.00$-200.00-20.00%Miss-10.3%
    Mar 20
    Reported May 11
    		$-0.28$-0.31+9.68%Beat+17.6%
    Dec 19
    Reported Mar 16
    		$-307.50$-197.50-55.70%Miss+6.8%
    Sep 19
    Reported Nov 12
    		$-187.50$-197.50+5.06%Beat+10.7%
    Jun 19
    Reported Aug 9
    		$-217.50$-187.50-16.00%Miss-52.6%
    Mar 19
    Reported May 10
    		$-0.34$-0.36+5.56%Beat+99.8%
    Dec 18
    Reported Mar 18
    		$-330.00$-202.50-62.96%Miss-53998.4%
    Sep 18
    Reported Nov 13
    		$-210.00$-187.50-12.00%Miss-77677.8%
    Jun 18
    Reported Aug 13
    		$-142.50$-187.50+24.00%Beat-67757.1%
    Mar 18
    Reported May 14
    		$-180.00$-172.50-4.35%Miss-128471.4%
    Dec 17
    Reported Mar 29
    		$-0.61$-0.24-154.17%Miss-
    Sep 17
    Reported Nov 14
    		$-0.27N/AN/ABeat-
    Jun 17
    Reported Aug 14
    		$-0.21N/AN/ABeat-
    Mar 17
    Reported May 15
    		$-0.14N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.86EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-58.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta2.09Avg Volume43.19K
    52-Week High$1.6952-Week Low$0.37

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.42
    SMA 20$0.46
    SMA 50$0.52
    SMA 200$0.73
    EMA 10$0.42
    EMA 20$0.45
    EMA 50$0.51
    EMA 200$0.74

    MACD

    Line: -0.04Signal: -0.03Hist: -0.01

    ADX

    ADX: 41.0+DI: 13.1-DI: 27.9

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down100.0
    PSAR$0.45

    Bollinger Bands

    Upper Band$0.58
    Lower Band$0.35
    %B Position4870%(Upper)
    Band Width0.15

    RSI (14-Day)

    Oversold
    28.6

    Momentum Oscillators

    Stoch %K3.7
    Stoch %D7.0
    Williams %R-90.0
    ROC (10d)-17.6%
    Momentum-0.08
    CCI (20d)-129.7
    MFI (14d)34.1

    Volatility Measures

    ATR (14d)$0.03(8.3%)
    StdDev (20d)0.06
    Hist Vol68.1%(High)

    Volume Flow

    VWAP$0.38
    OBV297.1M
    AD Line-259.8M
    CMF (20d)-0.325

    Volume Metrics

    Avg Vol (20d)44.1K
    Vol Ratio0.7x
    VWMA (20d)$0.44

    Pivot Points

    R3$0.46
    R2$0.45
    R1$0.41
    Pivot Point$0.39
    S1$0.35
    S2$0.33
    S3$0.29

    Advanced Oscillators

    TSI-41.93
    Ultimate Osc28.4
    KST-199.14

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$1.99M$0$0$0$2.88M$0
    Cost of Revenue$0$0N/A$0$0$0$996,000$0$0$0$363,000$0
    Gross Profit$0$0N/A$0$0$0$996,000$0$0$0$2.52M$0
    Operating Expenses$1.17M$1.06M$670,000$624,000$885,000$253,000$1.02M$1.46M$8.54M$5.23M$8.74M$10.31M
    R&D$224,000$178,000$-317,000$-333,000$98,000$-964,000$197,000$57,000$4.36M$3.80M$6.68M$9.53M
    SG&A$946,000$880,000$987,000$957,000$787,000$1.22M$-223,000$1.40M$1.53M$1.43M$2.18M$2.13M
    Operating Income$-1,170,000$-1,058,000$-670,000$-624,000$-885,000$-253,000$-1,017,000$-1,457,000$-8,540,000$-5,231,000$-8,741,000$-10,307,000
    Interest Income$98,000$103,000$132,000$156,000$123,000$100,000$65,000$47,000$27,000$40,000$123,000$115,000
    Interest Expense$0$0$0$0$0$0$0$0$0$0$-3,000$4,000
    Income Before Tax$-1,072,000$-955,000$-538,000$-468,000$-762,000$-153,000$-952,000$-1,410,000$-8,199,000$-5,191,000$-8,616,000$-10,058,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-1,072,000$-955,000$-538,000$-468,000$-762,000$-153,000$-952,000$-1,410,000$-8,199,000$-5,191,000$-8,616,000$-10,058,000
    EBITDA$-1,170,000$-1,058,000$-670,000$-624,000$-885,000$-212,000$-942,000$-1,406,000$-8,225,000$-4,535,000$-8,379,000$-9,802,000
    EBIT$-1,170,000$-1,058,000$-670,000$-624,000$-885,000$-253,000$-1,017,000$-1,457,000$-8,226,000$-5,231,000$-8,742,000$-10,169,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MBIO

    News

    Mustang Bio gets Nasdaq reprieve. Mustang Bio stock needs USD 1.00 bids

    Mustang Bio (MBIO) has received a second 180-day grace period from Nasdaq, extending its deadline to April 12, 2027...

    ad-hoc-news.de•10/16/26•Bearish

    Mustang Bio stock sits 2.70 percent above its yearly low

    Mustang Bio's stock is trading at $0.38, just 2.70% above its 52-week low of $0.37. The clinical-stage biotechnology company reported $15.2 million in cash for Q2 2026, with a net loss of $1.1 million...

    ad-hoc-news.de•10/13/26•Neutral

    MBIO stock sits near its 52-week low as Nasdaq deadline nears

    Mustang Bio's stock (MBIO) is trading near its 52-week low at USD 0.460, with a critical Nasdaq compliance deadline approaching on October 12...

    AD HOC NEWS•10/6/26•Bearish

    MBIO stock falls 1.91 percent as Q2 loss widens

    Mustang Bio's stock (MBIO) fell 1.91% to USD 0.46 on October 5, 2026, after the company reported a wider Q2 net loss of USD 1.1 million, up from USD 762,000 a year prior. The clinical-stage biopharmaceutical company...

    AD HOC NEWS•10/5/26•Bearish

    MUSTANG BIO, INC. Q2 2026: Net income $(1.07)M, EPS $(0.16) — 10-Q Summary

    MUSTANG BIO, INC. (MBIO) reported a wider net loss in Q2 2026, with net income (loss) of $(1.07)M compared to $(0.76)M in Q2 2025. Diluted loss per share was $(0.16), an improvement from $(0.19) in the previous year...

    TradingView•8/6/26•Neutral

    MBIO Valuation and Fair Value

    P/E
    -0.9x
    P/B
    0.3x
    See GNG's fair value

    MBIO Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -58.1%

    MBIO Competitors

    CompanyTicker
    Cadrenal Therapeutics, Inc. Common StockCVKD
    GRI Bio Inc.GRI
    60 Degrees Pharmaceuticals, Inc. Common StockSXTP
    XORTX Therapeutics IncXRTX
    Clearmind Medicine Inc. Common SharesCMND
    Ridgetech, Inc.RDGT
    Calidi Biotherapeutics Inc.CLDI
    Onconetix IncONCO

    Sector: Healthcare

    MBIO Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    13.2%

    Frequently Asked Questions About MBIO

    Does MBIO pay dividends?

    Mustang Bio Inc (MBIO) does not currently pay a regular dividend.

    What is MBIO's market cap?

    Mustang Bio Inc (MBIO) has a market capitalization of $3.08M with a current stock price of $0.39.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In